By linking academia with industry and financial partners, and through its special relationship with IRIC, IRICoR has been innovating for nearly 15 years in the way it transforms drug discoveries into therapies for the benefit of patients.
IRICoR is proud to have collaborated on the XTRA La Presse+ edition – Montreal: a hub of health and innovation.
Through an interview with Elizabeth Douville, PhD, ICD.D , President and CEO of IRICoR, discover the genesis of our organization, its many successes and achievements, and how this unique gas pedal is helping to make Montreal a hub of innovation in the health sciences.
To read the article: http://bit.ly/3sT3yv3